{"id":7082,"date":"2025-05-22T13:46:38","date_gmt":"2025-05-22T10:46:38","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7082"},"modified":"2025-05-22T13:46:38","modified_gmt":"2025-05-22T10:46:38","slug":"imaging-modalities-for-detecting-non-calcified-atherosclerotic-plaques-ncps","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/imaging-modalities-for-detecting-non-calcified-atherosclerotic-plaques-ncps\/","title":{"rendered":"Imaging Modalities for Detecting Non-Calcified Atherosclerotic Plaques (NCPs)"},"content":{"rendered":"
Imaging Modalities for Detecting Non-Calcified Atherosclerotic Plaques (NCPs):<\/div>\n
<\/div>\n
Non-calcified plaques (NCPs) represent lipid-rich, fibrous, or inflamed lesions that may not be detected by traditional calcium scoring. Multiple imaging modalities beyond CT can help identify such plaques\u2014either anatomically or by detecting biological activity.<\/div>\n
<\/div>\n
1. Cardiac MRI (CMR)<\/div>\n
\u2022 Type: Non-invasive, no ionizing radiation<\/span><\/div>\n
\u2022 Capabilities:<\/span><\/div>\n
\u2022 Wall thickness and vessel remodeling<\/span><\/div>\n
\u2022 T1\/T2 mapping may help characterize fibrous vs lipid-rich plaques<\/span><\/div>\n
\u2022 Contrast-enhanced MR angiography can partially show vessel lumen<\/span><\/div>\n
\u2022 Limitations:<\/span><\/div>\n
\u2022 Limited spatial resolution for coronary arteries<\/span><\/div>\n
\u2022 Used primarily for large vessels (e.g., carotid, aorta)<\/span><\/div>\n
\u2022 Role: Research and selective clinical use for vascular inflammation or plaque burden<\/span><\/div>\n
<\/div>\n
2. Intravascular Ultrasound (IVUS)<\/div>\n
\u2022 Type: Invasive (catheter-based)<\/span><\/div>\n
\u2022 Capabilities:<\/span><\/div>\n
\u2022 Direct imaging of vessel wall and plaque burden<\/span><\/div>\n
\u2022 Differentiates calcified from non-calcified plaque<\/span><\/div>\n
\u2022 Role: Gold standard for plaque volume and burden in PCI settings<\/span><\/div>\n
<\/div>\n
3. Optical Coherence Tomography (OCT)<\/div>\n
\u2022 Type: Invasive (high-resolution catheter)<\/span><\/div>\n
\u2022 Capabilities:<\/span><\/div>\n
\u2022 Ultra-high resolution (~10 \u00b5m)<\/span><\/div>\n
\u2022 Visualizes fibrous cap thickness, lipid cores, and plaque rupture<\/span><\/div>\n
\u2022 Limitations:<\/span><\/div>\n
\u2022 Requires blood clearance with contrast<\/span><\/div>\n
\u2022 Small imaging depth<\/span><\/div>\n
\u2022 Role: Best for characterizing vulnerable plaques in acute coronary syndrome<\/span><\/div>\n
<\/div>\n
4. Carotid Ultrasound<\/div>\n
\u2022 Type: Non-invasive<\/span><\/div>\n
\u2022 Capabilities:<\/span><\/div>\n
\u2022 Identifies plaque morphology and intima-media thickness (IMT)<\/span><\/div>\n
\u2022 May detect soft plaques in carotids but not coronary arteries<\/span><\/div>\n
\u2022 Role: Screening tool for systemic atherosclerosis in asymptomatic individuals<\/span><\/div>\n
<\/div>\n
5. PET Imaging (Positron Emission Tomography)<\/div>\n
\u2022 Type: Functional\/biological imaging<\/span><\/div>\n
\u2022 Radiotracers:<\/span><\/div>\n
\u2022 FDG (18F-fluorodeoxyglucose) \u2192 detects macrophage-driven inflammation<\/span><\/div>\n
\u2022 NaF (18F-sodium fluoride) \u2192 detects microcalcification, an early feature of plaque destabilization<\/span><\/div>\n
\u2022 Applications:<\/span><\/div>\n
\u2022 Identifying biologically active (vulnerable) plaques<\/span><\/div>\n
\u2022 Evaluating response to therapies (e.g., statins)<\/span><\/div>\n
\u2022 Limitations:<\/span><\/div>\n
\u2022 Low spatial resolution<\/span><\/div>\n
\u2022 Coronary imaging is challenging due to cardiac motion and myocardial FDG uptake<\/span><\/div>\n
\u2022 Role: Primarily research, selective use in large-vessel atherosclerosis<\/span><\/div>\n
<\/div>\n
6. PET\/MRI (Hybrid Imaging)<\/div>\n
\u2022 Type: Combined molecular and anatomical imaging<\/span><\/div>\n
\u2022 Capabilities:<\/span><\/div>\n
\u2022 PET: Detects inflammation or microcalcification<\/span><\/div>\n
\u2022 MRI: Assesses plaque morphology, intraplaque hemorrhage, vessel remodeling<\/span><\/div>\n
\u2022 Synergistic view of plaque biology + structure<\/span><\/div>\n
\u2022 Advantages:<\/span><\/div>\n
\u2022 Reduced radiation compared to PET\/CT<\/span><\/div>\n
\u2022 Superior soft tissue contrast from MRI<\/span><\/div>\n
\u2022 Limitations:<\/span><\/div>\n
\u2022 High cost, limited availability<\/span><\/div>\n
\u2022 Still under research for coronary arteries<\/span><\/div>\n
\u2022 Role: Ideal in research and high-risk carotid\/aortic imaging; expanding clinical interest<\/span><\/div>\n
<\/div>\n
https:\/\/www.escardio.org\/Education\/ESC-Scientific-Document-Library\/SCORE2-new-CVD-risk-assessment-in-Europe<\/a><\/div>\n
https:\/\/tools.acc.org\/ASCVD-Risk-Estimator-Plus<\/a><\/div>\n
https:\/\/www.qrisk.org\/three\/<\/a><\/div>\n
https:\/\/www.mdcalc.com\/calc\/61\/framingham-risk-score-hard-coronary-heart-disease<\/a><\/div>\n
https:\/\/www.reynoldsriskscore.org\/<\/a><\/div>\n
https:\/\/www.mesanhlbi.org\/MESACHDRisk\/MesaRiskScore\/RiskScore.aspx<\/a><\/div>\n
https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000946<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Imaging Modalities for Detecting Non-Calcified Atherosclerotic Plaques (NCPs): Non-calcified plaques (NCPs) represent lipid-rich, fibrous, or inflamed lesions that may not be detected by traditional calcium scoring. Multiple imaging modalities beyond CT can help identify such plaques\u2014either anatomically or by detecting biological activity. 1. Cardiac MRI (CMR) \u2022 Type: Non-invasive, no ionizing radiation \u2022 Capabilities: \u2022 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7082","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7082"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7082\/revisions"}],"predecessor-version":[{"id":7084,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7082\/revisions\/7084"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}